Xencor, Inc. (XNCR)

31.36
NASDAQ
Prev Close 31.06
Day Low/High 30.00 / 31.85
52 Wk Low/High 27.57 / 48.38
Exchange NASDAQ
Shares Outstanding 56.29B
Market Cap 1.75B
Div & Yield N.A. (N.A)

Latest News

Xencor Announces Closing Of Research Collaboration And License Agreement With Genentech

Xencor Announces Closing Of Research Collaboration And License Agreement With Genentech

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer, today announced the closing of its research collaboration...

Xencor Reports Fourth Quarter And Full Year 2018 Financial Results

Xencor Reports Fourth Quarter And Full Year 2018 Financial Results

- Initial Data from Phase 1 Study of XmAb®14045 Presented at ASH 2018; Multiple Complete Remissions Achieved in Advanced AML Patient Population; Study on Partial Clinical Hold Pending Resolution with FDA -

Xencor Announces Partial Clinical Hold On Phase 1 Study Of XmAb14045

Xencor Announces Partial Clinical Hold On Phase 1 Study Of XmAb14045

MONROVIA, Calif., Feb.

Xencor To Present At Upcoming Investor Conferences

Xencor To Present At Upcoming Investor Conferences

MONROVIA, Calif., Feb.

Xencor To Develop And Commercialize Novel IL-15 Immune Activating Cytokines With Genentech

Xencor To Develop And Commercialize Novel IL-15 Immune Activating Cytokines With Genentech

-- Xencor Receives $120 Million Upfront Payment, up to $180 Million in Development Milestones Per Program and Profit Share from Commercialized Medicines

Xencor Regains Ex-U.S. Commercial Rights To XmAb®13676, CD20 X CD3 Bispecific Antibody

Xencor Regains Ex-U.S. Commercial Rights To XmAb®13676, CD20 X CD3 Bispecific Antibody

-- Initial data from the ongoing Phase 1 study in patients with B-cell malignancies expected in 2019 --

Xencor To Present At 30th Annual Piper Jaffray Healthcare Conference

Xencor To Present At 30th Annual Piper Jaffray Healthcare Conference

MONROVIA, Calif., Nov.

Xencor Appoints Ellen G. Feigal, M.D., To Board Of Directors

Xencor Appoints Ellen G. Feigal, M.D., To Board Of Directors

MONROVIA, Calif., Nov.

Xencor Reports Third Quarter 2018 Financial Results

Xencor Reports Third Quarter 2018 Financial Results

- Initial Data from Phase 1 Dose-Escalation Study of XmAb®14045 in Acute Myeloid Leukemia (AML) to Be Presented at 2018 ASH Annual Meeting -

First Week Of May 2019 Options Trading For Xencor (XNCR)

First Week Of May 2019 Options Trading For Xencor (XNCR)

Investors in Xencor, Inc saw new options begin trading this week, for the May 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 227 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Xencor Is Now Oversold (XNCR)

Xencor Is Now Oversold (XNCR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting XNCR Put And Call Options For August 17th

Interesting XNCR Put And Call Options For August 17th

Investors in Xencor, Inc saw new options become available this week, for the August 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 171 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Xencor is Now Oversold (XNCR)

Xencor is Now Oversold (XNCR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Short Interest In Xencor Expands By 24%

The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 523,227 share increase in total short interest for Xencor, Inc , to 2,709,849, an increase of 23.93% since 05/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARII, BPI, CHS, EMXX, GCO, GVP, HAYN, HEES, SMTC, UEPS, XNCR Downgrades: ABT, ACHC, ARL, ARRS, EVK, FSI, NTWK, PIH, WUBA Initiations: PXS Read on to get TheStreet Quant Ratings' detailed report:

Light Volume Dims Market's Outlook

I day-traded ProShares Ultra QQQ ETF and held my Baozun shares.

Copper Shines, Retail Rises

Inflationary expectations and stronger consumer sentiment anticipate a Trump administration's new policies.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CSWC, FNV, INTT, SCHL, VSAT Downgrades: AE, ASH, CNTY, CVV, HCOM, JAZZ, JLL, KND, MAC, MGNX, NS, OLED, OLP, SCSC, SEAS, TGH, XNCR Initiations: ABTX Read on to get TheStreet Quant Ratings' detailed report:

Oversold Conditions For Xencor (XNCR)

Oversold Conditions For Xencor (XNCR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Strong On High Volume: Xencor (XNCR)

Strong On High Volume: Xencor (XNCR)

Trade-Ideas LLC identified Xencor (XNCR) as a strong on high relative volume candidate

4 Momentum Stocks You Should Be Watching Right Now

4 Momentum Stocks You Should Be Watching Right Now

Here are the charts of four must-watch stocks that have strong technical momentum.

X(encor) Marks the Spot For Potential Gains

X(encor) Marks the Spot For Potential Gains

You have to be impressed by the breadth of XNCR's pipeline and significant partnerships with major players.

5 Stocks I Like for 2016's Second Half

5 Stocks I Like for 2016's Second Half

From Celgene to Ford, these names look promising.

Strong On High Volume: Xencor (XNCR)

Strong On High Volume: Xencor (XNCR)

Trade-Ideas LLC identified Xencor (XNCR) as a strong on high relative volume candidate

TheStreet Quant Rating: C- (Hold)